
201 - 500 employees
Founded 2000
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
Biotechnology • Pharmaceuticals • Science
Immatics is a biotechnology company focused on developing targeted immunotherapies for cancer patients, particularly in treating solid tumors. The company combines the discovery of cancer immunotherapy targets with the development of specific T cell receptors to enable a robust immune response. Immatics' pipeline includes Adoptive Cell Therapies and TCR Bispecifics, and it collaborates with global leaders in the pharmaceutical industry. The company's mission is to advance its therapies to improve the lives of cancer patients, and it maintains a strong commitment to innovation in immunotherapy technologies.
🕒 4 days ago
Director of Medical Affairs Operations leading operational strategy in precision targeting for cancer therapies. Collaborating with teams to ensure effective medical strategy execution and compliance standards.
🕒 4 days ago
Senior Clinical Research Associate overseeing site management and monitoring activities for clinical trials at Immatics. Supporting compliance with ICH-GCP, regulatory requirements, and company SOPs.
🕒 July 9
Senior Director, Payer Accounts shaping U.S. market access strategy at Immatics. Leading engagement with national and regional payers for cell therapy launch.
🕒 June 25
Clinical Trial Manager overseeing site management and compliance in cancer immunotherapy trials. Collaborating with diverse teams to drive study execution and operational excellence.